Join us for a webinar organised in partnership with Mewburn Ellis, one of Europe’s top specialist IP firms that has made a name for itself working with numerous local biotechs over the last decade, including MIRXES, Enleofen Bio, Hummingbird Bioscience, and the recently launched VVB Bio. In this seminar, we cover:
- Identifying Protection Opportunities for Platform TechnologiesBI Venture Fund
- Strategies to Minimise Impact of Platform Filings on Future Filings
- Importance of Timing in Platform and Product Filings
Don’t miss this chance to learn from and gain insights from one of Europe’s top specialist IP firms. Follow the link or scan the QR code to register now!
📅: 25 January 2024, Thursday
🕚: 11:30am – 12:30pm
📍: Zoom webinar
This is a fully virtual event – your zoom link will be sent to the indicated email address shortly after registration.
Due to the sensitivity of information to be presented and the speaker’s preference, we strongly advise against capturing the contents of the slides through any form of media.
Kindly note that screen captures may be taken during this event. By taking part in this event, you are consenting that images taken during the event can be used by EDDC for any form of publicity including but not limited to our website, social media and publication purposes.
By registering for this webinar, you hereby agree that EDDC may collect, obtain, store and process your personal data for a relevant calendar invite for the above-mentioned webinar. Your information will not be disclosed externally or be kept beyond this seminar.